Propionic Acid

Propionic Acid

SCHEMBL4153189

CCC(=O)O.O=c1[nH]c2ccc(SCc3ccccc3)cc2c2cc[nH]c12

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 4/20 0.41
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MAPT P10636 3/20 0.38
ALDH1A1 P00352 4/20 0.36
HPGD P15428 1/20 0.36
KDM4E B2RXH2 2/20 0.36
PARP1 P09874 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
XDH P47989 1/20 0.34
HAO1 Q9UJM8 1/20 0.34
KDM6B O15054 1/20 0.34
KDM4A O75164 1/20 0.34
KDM4D Q6B0I6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4162079 0.86 PLA2G1B (0.39) MAOAMAOBMAPTALDH1A1HPGD
Propionic Acid SCHEMBL4164365 0.85 MAPT (0.34) MAPTALDH1A1HPGDKDM4EPARP1
Propionic Acid SCHEMBL4155437 0.82 PPARG (0.46) DAOMAPTALDH1A1HPGDKDM4E
Propionic Acid SCHEMBL4153840 0.81 PIM1 (0.44) MAPTALDH1A1HPGDKDM4EMEN1
Propionic Acid SCHEMBL4171576 0.79 PIM1 (0.46) DAOMAPTALDH1A1HPGDKDM4E
Propionic Acid SCHEMBL4153652 0.78 MAOA (0.39) MAOAMAOBMAPTALDH1A1HPGD
Propionic Acid SCHEMBL4159927 0.78 ALDH1A1 (0.40) MAPTALDH1A1HPGDKDM4EMEN1
Propionic Acid SCHEMBL4155354 0.77 PAK1 (0.50) MAPTALDH1A1HPGD
Propionic Acid SCHEMBL4153028 0.77 ALDH1A1 (0.36) MAPTALDH1A1HPGDKDM4EPARP1
Propionic Acid SCHEMBL4160624 0.77 MPO (0.43) KDM4EPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 DAO 2645/4885MAOA 2903/4885MAOB 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.